ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,640.00
-0.50 (-0.03%)
Last Updated: 10:14:25
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.03% 1,640.00 1,639.00 1,640.00 1,647.00 1,635.00 1,638.50 496,541 10:14:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.72 67.6B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,640.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £67.60 billion. Gsk has a price to earnings ratio (PE ratio) of 13.72.

Gsk Share Discussion Threads

Showing 22326 to 22350 of 33100 messages
Chat Pages: Latest  904  903  902  901  900  899  898  897  896  895  894  893  Older
DateSubjectAuthorDiscuss
14/10/2020
12:48
Interesting article I ask myself the same question.
montyhedge
14/10/2020
11:26
Certainly gives alot to our overpaid CEO!
geckotheglorious
14/10/2020
10:53
Don't you just love GSK, the stock that keeps giving. I like the February dividend 23p.
montyhedge
14/10/2020
10:38
4 weeks to go till holders qualify for next GSK dividend..... ;0)
tradermichael
14/10/2020
10:01
"Lilly’s proposed treatment is intended for hospitalized patients with severe cases of COVID-19. It is similar to the treatment made by Regeneron that was given to President Trump earlier this month. The trial is testing a combination of two lab-engineered immune system proteins called monoclonal antibodies to treat severely ill patients with coronavirus. Eli Lilly said the trial’s Data Safety Monitoring Board (DSMB) recommended the pause".

(Not a vaccine candidate).

alphorn
14/10/2020
09:57
https://www.independent.co.uk/news/world/americas/coronavirus-treatment-trial-antibody-safety-eli-lily-b1016702.html
montyhedge
14/10/2020
09:43
mh - Lilly's compound is not a vaccine.
alphorn
14/10/2020
09:41
The latest to fall at the fence Lily. The final furlong will be Astra and GSK coming up to the winning post.Don't forget GSK have two runners, they are supplying tech know how to a Chinese Bio company.
montyhedge
14/10/2020
09:18
Monty
"Gsk/Sanofi I still reckon will be first in the vaccine race, most experienced in vaccines, has the other runners start falling at the first fence"

PFE?

geckotheglorious
14/10/2020
09:00
Gsk been raised to BUY this morning by Intron Health, target 1700p.
montyhedge
14/10/2020
08:57
Gsk/Sanofi I still reckon will be first in the vaccine race, most experienced in vaccines, has the other runners start falling at the first fence.
montyhedge
14/10/2020
08:51
Given that some kind of Covid-19 vaccine emerges, it seems that it may take a long time before a mass vaccination program can be undertaken. If the program with limited supply is to be staged first across age groups and critical workers, my thoughts are that very old people (who are apparently more at risk) should not be 'first in the queue'. Instead, they should be shielded until its their turn. Its the younger people that should be vaccinated first. Students (18+) up to 35 (critical to maintain the economy) and beyond. The reason is, this group mixes more socially, is more mobile in the community and doesn't seem to 'obey the rules', becoming 'super-spreaders'. Once this step has reduced infection rates in that group, and once more vaccine supplies are available, then the program could move on to further protect the aged and more vulnerable.
tradermichael
14/10/2020
08:44
Another COVID vaccine pause announced yesterday, two this week.

GSK getting some support perhaps as a result.

essentialinvestor
14/10/2020
08:42
I'll be avoiding the flu jab myself..
Maintain healthy diet and extra Vitamin C/Vitamin d, Elderberry syrup etc to boost my immune system.

geckotheglorious
13/10/2020
16:47
Ok thanks.
montyhedge
13/10/2020
14:01
monty, Tesco Brooklands.

They are only accepting those eligible for a free flu jab on the NHS atm (I think).

essentialinvestor
13/10/2020
14:00
You were lucky shortage of flu vaccine.
montyhedge
13/10/2020
14:00
Good luck with that!
tradermichael
13/10/2020
13:55
Have my flu jab later today, joy, not.
essentialinvestor
13/10/2020
13:53
Based on current data, it seems as though SARS-CoV-2 mutates much more slowly than the seasonal flu. Specifically, SARS-CoV-2 seems to have a mutation rate of less than 25 mutations per year, whereas the seasonal flu has a mutation rate of almost 50 mutations per year.

Given that the SARS-CoV-2 genome is almost twice as large as the seasonal flu genome, it seems as though the seasonal flu mutates roughly four times as fast as SARS-CoV-2. The fact that the seasonal flu mutates so quickly is precisely why it is able to evade our vaccines, so the significantly slower mutation rate of SARS-CoV-2 gives us hope for the potential development of effective long-lasting vaccines against the virus.

tradermichael
13/10/2020
11:51
Yes, but for maximum hysteria value, its not featured on a tabloid or broadsheet front page yet! spud
spud
13/10/2020
11:39
Spud
Post 22327
"The next headline when not enough people are being reinfected will be the Mutating Virus!"

Covered already surely?

"A comparison of genetic codes showed "significant differences" between each virus variant" ie a mutation!

geckotheglorious
13/10/2020
11:24
The next headline when not enough people are being reinfected will be the Mutating Virus! Don't forget, you heard it here first..spud
spud
13/10/2020
10:51
It could be a one in a million event, we don't know.

Neither do we known how long any immunity lasts following infection.

As many people were infected in March and there are exceptionally few confirmed

cases of reinfection, it appears to be 6 months or longer.

essentialinvestor
13/10/2020
10:37
It's the media's dream headline! I'm not getting sucked in as the odds are so low as to be uncalculable. If the media can spin this for another 12 months, they'll use every tenuous weapon in their armoury. spud
spud
Chat Pages: Latest  904  903  902  901  900  899  898  897  896  895  894  893  Older

Your Recent History

Delayed Upgrade Clock